CAN
AXSM icon

Cetera Advisor Networks’s Axsome Therapeutics AXSM Stock Holding History

Cetera Advisor Networks’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$262K Buy
+3,281
New +$275K ﹤0.01% 2386

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Advisor Networks's AXSM Position: Q1 2024 in Review

Cetera Advisor Networks opened a new position in Axsome Therapeutics (AXSM) in Q1 2024: 3,281 shares worth $262K. The stake represents ﹤0.01% of the portfolio and ranks #2386 among its holdings.

260 funds tracked by Wall St. Rank hold AXSM as of Q1 2024.

  • Cetera Advisor Networks held 3,281 shares of Axsome Therapeutics worth $262K as of Q1 2024.
  • Axsome Therapeutics was a new Cetera Advisor Networks position in Q1 2024.
  • Axsome Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2386 holding.
  • 260 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.